Homepage Bottom Left
-
British Columbia, Ontario approve access to gene therapy for hemophilia B
Montreal – April 3, 2026 – In the last few weeks, British Columbia and Ontario have approved access to HEMGENIX, gene therapy for hemophilia B....
-
Honouring the Life and Legacy of Marion Stolte
By Sarah Ford The Canadian bleeding disorders community mourns the passing of longtime volunteer and advocate Marion Stolte, whose dedication and leadership helped improve the...
-
PROBE Survey Reminder, News for People with VWD
Montreal, February 27, 2026 – A group of MyCBDR users will have received an email in recent days inviting them to complete the PROBE survey....
-
BEYOND-9 hemophilia B gene therapy clinical trial launched in four Canadian study sites
Montreal, February 5, 2026 – Four Canadian bleeding disorder treatment centres are participating in the Phase 1 clinical trial of Regeneron’s CRISPR/Cas9-based targeted gene insertion...
-
Recruitment at the Board of Directors
You would like to have a significant impact in the Canadian bleeding disorder community? Here’s your chance, the CHS Board of Directors is recruiting. Please...